Last updated on August 2018

Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS

Brief description of study

Multicenter, multiple dose study to examine the effect of H.P. Acthar Gel (repository corticotropin injection) in adult subjects with idiopathic focal segmental glomerulosclerosis (FSGS) who have failed to achieve remission with, or who are intolerant of, 1 or more previous immunosuppressive therapies.

Clinical Study Identifier: NCT02633046

Contact Investigators or Research Sites near you

Start Over

Valerie Carvajal

Renal Research Group
Gosford, Australia
  Connect »